Correlation Between Beam Therapeutics and Pliant Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Beam Therapeutics and Pliant Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beam Therapeutics and Pliant Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Beam Therapeutics and Pliant Therapeutics, you can compare the effects of market volatilities on Beam Therapeutics and Pliant Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beam Therapeutics with a short position of Pliant Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beam Therapeutics and Pliant Therapeutics.

Diversification Opportunities for Beam Therapeutics and Pliant Therapeutics

0.12
  Correlation Coefficient

Average diversification

The 3 months correlation between Beam and Pliant is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Beam Therapeutics and Pliant Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pliant Therapeutics and Beam Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beam Therapeutics are associated (or correlated) with Pliant Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pliant Therapeutics has no effect on the direction of Beam Therapeutics i.e., Beam Therapeutics and Pliant Therapeutics go up and down completely randomly.

Pair Corralation between Beam Therapeutics and Pliant Therapeutics

Given the investment horizon of 90 days Beam Therapeutics is expected to generate 1.91 times more return on investment than Pliant Therapeutics. However, Beam Therapeutics is 1.91 times more volatile than Pliant Therapeutics. It trades about 0.18 of its potential returns per unit of risk. Pliant Therapeutics is currently generating about -0.07 per unit of risk. If you would invest  2,293  in Beam Therapeutics on September 2, 2024 and sell it today you would earn a total of  444.00  from holding Beam Therapeutics or generate 19.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Beam Therapeutics  vs.  Pliant Therapeutics

 Performance 
       Timeline  
Beam Therapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Beam Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain basic indicators, Beam Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.
Pliant Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Pliant Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Pliant Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Beam Therapeutics and Pliant Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Beam Therapeutics and Pliant Therapeutics

The main advantage of trading using opposite Beam Therapeutics and Pliant Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beam Therapeutics position performs unexpectedly, Pliant Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pliant Therapeutics will offset losses from the drop in Pliant Therapeutics' long position.
The idea behind Beam Therapeutics and Pliant Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Fundamental Analysis
View fundamental data based on most recent published financial statements